
3D-OHA 1mg/500mg/15mg Tablet
Marketer
Strides shasun Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview 3D-OHA 1mg/500mg/15mg Tablet
Metformin/Pioglitazone/Glimepiride 1mg/500mg/15mg tablets are a triple-combination medication for managing blood glucose. This therapy, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It improves insulin effectiveness, thus reducing blood sugar. Dosage and regimen should strictly follow your physician's instructions. Take with food to minimize digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; in that case, skip the missed dose and resume your usual schedule. Never double the dose. An overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood sugar monitoring is vital. Common side effects include nausea, diarrhea, abdominal pain, headache, fractures, and respiratory infections. Inform your doctor of any pre-existing kidney, liver, or heart conditions before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Kidney function tests will be assessed before treatment initiation. Limit alcohol consumption to mitigate potential side effects.
Uses of 3D-OHA 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of 3D-OHA 1mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume the 3D-OHA 1mg/500mg/15mg tablet with food.
Common Side effects of 3D-OHA 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use 3D-OHA 1mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the 3D-OHA 1mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Consume with food.
How 3D-OHA 1mg/500mg/15mg Tablet works:
The antidiabetic medication 3D-OHA (1mg/500mg/15mg tablet) combines glimepiride, metformin, and pioglitazone, each acting via distinct pathways to optimize blood sugar management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, reducing blood glucose levels. Metformin, a biguanide, diminishes hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and 3D-OHA 1mg/500mg/15mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of 3D-OHA 1mg/500mg/15mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of 3D-OHA 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with either hypoglycemia or hyperglycemia. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use the 3D-OHA 1mg/500mg/15mg Tablet cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated for individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use 3D-OHA 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. The use of 3D-OHA 1mg/500mg/15mg tablets is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take 3D-OHA 1mg/500mg/15mg Tablet :
Should you forget to take your 3D-OHA 1mg/500mg/15mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About 3D-OHA 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
